Has the FDA approved a new drug for both active and chronic phases of TED?
The FDA has given the green light to Lumvoa, a groundbreaking drug for thyroid eye disease (TED), marking a significant milestone in treatment options. Lumvoa,...
This website uses cookies to improve your experience. We assume you agree, but you can opt out if you wish. Accept More Info